SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001701541-23-000047
Filing Date
2023-11-06
Accepted
2023-11-06 07:14:57
Documents
59
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bdtx-20230930.htm   iXBRL 10-Q 937421
2 EX-31.1 exhibit311_q32023.htm EX-31.1 12493
3 EX-31.2 exhibit312_q32023.htm EX-31.2 12267
4 EX-32.1 exhibit321_q32023.htm EX-32.1 9317
  Complete submission text file 0001701541-23-000047.txt   4747880

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bdtx-20230930.xsd EX-101.SCH 29974
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bdtx-20230930_cal.xml EX-101.CAL 51989
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bdtx-20230930_def.xml EX-101.DEF 116196
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bdtx-20230930_lab.xml EX-101.LAB 447904
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bdtx-20230930_pre.xml EX-101.PRE 275282
53 EXTRACTED XBRL INSTANCE DOCUMENT bdtx-20230930_htm.xml XML 646208
Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Filer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39200 | Film No.: 231378097
SIC: 2836 Biological Products, (No Diagnostic Substances)